TrialNature communications2025

Plasma exchange therapy for the post COVID-19 condition: a phase II, double-blind, placebo-controlled, randomized trial.

Sergio España-Cueto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.